The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases - EP3227333

The patent EP3227333 was granted to Bristol Myers Squibb on Aug 16, 2023. The application was originally filed on Dec 2, 2015 under application number EP15804458A. The patent is currently recorded with a legal status of "Revoked".

EP3227333

BRISTOL MYERS SQUIBB
Application Number
EP15804458A
Filing Date
Dec 2, 2015
Status
Revoked
Aug 22, 2025
Publication Date
Aug 16, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERMay 16, 2024PFIZERADMISSIBLE
SCORPIOMay 16, 2024SAGITTARIUSADMISSIBLE
J A KEMPMay 14, 2024J A KEMPADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2009032058
INTERNATIONAL-SEARCH-REPORTWO2012143498
INTERNATIONAL-SEARCH-REPORTWO2013072406
INTERNATIONAL-SEARCH-REPORTWO2014122143
INTERNATIONAL-SEARCH-REPORTWO2014140248
OPPOSITIONEP2982692
OPPOSITIONWO2009132058
OPPOSITIONWO2012143498
OPPOSITIONWO2013026839
OPPOSITIONWO2013072406
OPPOSITIONWO2013072415
OPPOSITIONWO2014122143
OPPOSITIONWO2014122144
OPPOSITIONWO2014131712
OPPOSITIONWO2014140248
OPPOSITIONWO2014167022

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents